Genocea Biosciences, Inc. (GNCAQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Aug 8, 2025, 4:00 PM EDT
Genocea Biosciences Revenue
Genocea Biosciences had revenue of $270.00K in the quarter ending March 31, 2022. This brings the company's revenue in the last twelve months to $1.91M, up 40.62% year-over-year. In the year 2021, Genocea Biosciences had annual revenue of $1.64M with 20.75% growth.
Revenue (ttm)
1.91M
Revenue Growth
+40.62%
P/S Ratio
0.00
Revenue / Employee
25.82K
Employees
74
Market Cap
59.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 1.64M | 282.00K | 20.75% |
Dec 31, 2020 | 1.36M | - | - |
Dec 31, 2019 | - | - | - |
Dec 31, 2018 | - | - | - |
Dec 31, 2017 | - | - | - |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.17M |
BioStem Technologies | 332.45M |